Hangzhou Jiedi Biotechnology Co., Ltd. was established in 2017, focusing on the research and development and amplification of biotechnology products such as genetic recombination and peptide synthesis. It is an innovative bio-business with a mature and efficient R&D team. The subsidiary NOVA LABORATORIES PRIVATE LIMITED (India) is currently under construction and is expected to be put into production by 2020. It will serve as the main production and sales base for JD Bio. 

Jedi Bio has successfully developed a series of high-quality biomedical raw materials and biotechnology products using a unique E. coli secretory expression technology with independent intellectual property rights; including recombinant human bone morphogenetic protein-2 (rh-BMP-2) and hirudin ( Rhirudin), recombinant human superoxide dismutase (rhSOD),  and other products. 

The company has an independent professional R & D team, with a global research and development platform for E. coli secretion expression system, Pichia pastoris secretion expression system, animal cell secretion expression system. 

With the continuous investment of continuous high-level scientific research, the continuous introduction of high-quality products, and the continuous advancement of clinical experiments, we will build a more solid and progressive international biotechnology enterprise.